TY - JOUR
T1 - EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT
T2 - 2015 revision
AU - Verberne, Hein J
AU - Acampa, Wanda
AU - Anagnostopoulos, Constantinos
AU - Ballinger, Jim
AU - Bengel, Frank
AU - De Bondt, Pieter
AU - Buechel, Ronny R
AU - Cuocolo, Alberto
AU - van Eck-Smit, Berthe L F
AU - Flotats, Albert
AU - Hacker, Marcus
AU - Hindorf, Cecilia
AU - Kaufmann, Philip A
AU - Lindner, Oliver
AU - Ljungberg, Michael
AU - Lonsdale, Markus
AU - Manrique, Alain
AU - Minarik, David
AU - Scholte, Arthur J H A
AU - Slart, Riemer H J A
AU - Trägårdh, Elin
AU - de Wit, Tim C
AU - Hesse, Birger
AU - European Association of Nuclear Medicine (EANM)
PY - 2015/11
Y1 - 2015/11
N2 - Since the publication of the European Association of Nuclear Medicine (EANM) procedural guidelines for radionuclide myocardial perfusion imaging (MPI) in 2005, many small and some larger steps of progress have been made, improving MPI procedures. In this paper, the major changes from the updated 2015 procedural guidelines are highlighted, focusing on the important changes related to new instrumentation with improved image information and the possibility to reduce radiation exposure, which is further discussed in relation to the recent developments of new International Commission on Radiological Protection (ICRP) models. Introduction of the selective coronary vasodilator regadenoson and the use of coronary CT-contrast agents for hybrid imaging with SPECT/CT angiography are other important areas for nuclear cardiology that were not included in the previous guidelines. A large number of minor changes have been described in more detail in the fully revised version available at the EANM home page: http://eanm.org/publications/guidelines/2015_07_EANM_FINAL_myocardial_perfusion_guideline.pdf .
AB - Since the publication of the European Association of Nuclear Medicine (EANM) procedural guidelines for radionuclide myocardial perfusion imaging (MPI) in 2005, many small and some larger steps of progress have been made, improving MPI procedures. In this paper, the major changes from the updated 2015 procedural guidelines are highlighted, focusing on the important changes related to new instrumentation with improved image information and the possibility to reduce radiation exposure, which is further discussed in relation to the recent developments of new International Commission on Radiological Protection (ICRP) models. Introduction of the selective coronary vasodilator regadenoson and the use of coronary CT-contrast agents for hybrid imaging with SPECT/CT angiography are other important areas for nuclear cardiology that were not included in the previous guidelines. A large number of minor changes have been described in more detail in the fully revised version available at the EANM home page: http://eanm.org/publications/guidelines/2015_07_EANM_FINAL_myocardial_perfusion_guideline.pdf .
KW - Journal Article
U2 - 10.1007/s00259-015-3139-x
DO - 10.1007/s00259-015-3139-x
M3 - Journal article
C2 - 26290421
SN - 1619-7070
VL - 42
SP - 1929
EP - 1940
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
IS - 12
ER -